Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › ZVRA

SILVERARC CAPITAL MANAGEMENT, LLC position in ZVRA

ZEVRA THERAPEUTICS INC · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 200,260 shares of ZVRA (ZEVRA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 0.28% of its reported portfolio and ranking #50 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ZVRA holdings in 2 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)200.26K sh
Reported value held$2.20M
Portfolio Weight0.28%
First reportedQ3 2024
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's ZVRA position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in ZVRA in Q3 2024 at 350,000 shares (US$2.4M). Across 2 filings, SILVERARC CAPITAL MANAGEMENT, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 200,260 shares valued at US$2.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 350.00K $2.43M New
Q3 2026 200.26K $2.20M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZVRA and 13F data

ZVRA (ZEVRA THERAPEUTICS INC) is a Health Care company. 51 other funds we track also report a position in ZVRA — the largest reported positions include Nantahala Capital Management, LLC (US$25.8M), 683 Capital Management, LLC (US$12.3M), KINGDON CAPITAL MANAGEMENT, L.L.C. (US$11.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZVRA

All ZVRA fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held ZVRA?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ZVRA holdings in 2 of the last 9 reported quarters, going back to Q3 2024.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in ZVRA?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 200.26K shares of ZVRA (ZEVRA THERAPEUTICS INC), valued at $2.20M, representing 0.28% of its reported portfolio and ranking #50.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling ZVRA?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC newly opened its position in ZVRA.

Which other funds hold ZVRA?

Other major institutional holders of ZVRA include Nantahala Capital Management, LLC, 683 Capital Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.